Raphael Pharmaceutical (RAPH) Non Operating Income (2020 - 2024)
Raphael Pharmaceutical (RAPH) posted Non Operating Income of -$1000.0 for Q4 2024, up 85.71% sequentially from -$7000.0 in Q3 2024, and up 91.67% YoY from -$521.74 in Q1 2024.
Raphael Pharmaceutical (RAPH) Non Operating Income (2020 - 2024) Analysis & Trends
Raphael Pharmaceutical has reported Non Operating Income for 5 years, with the latest figure at -$1000.0 in Q4 2024.
- Quarterly Non Operating Income rose 91.67% year-over-year to -$1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$10000.0 (up 16.67% YoY) and the FY2025 annual result came in at -$34000.0, down 240.0% from the prior year.
- Non Operating Income rose to -$1000.0 in Q4 2024 per RAPH's latest filing, from -$7000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $7000.0 in Q4 2021 and troughed at -$17000.0 in Q3 2022.
- A 5-year average of -$3647.1 and a median of -$3000.0 in 2020 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2021 and 2023: Non Operating Income soared 333.33% in 2021, then sank 1300.0% in 2023.
- Over 5 years, Non Operating Income stood at -$3000.0 in 2020, then jumped by 333.33% to $7000.0 in 2021, then sank by 85.71% to $1000.0 in 2022, then tumbled by 1300.0% to -$12000.0 in 2023, then surged by 91.67% to -$1000.0 in 2024.
- According to Business Quant data, Non Operating Income over the past three periods registered -$1000.0, -$7000.0, and $1000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -24,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -3,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -6,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -17,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -10,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | -3,000.00 |
| Dec 31, 2020 | -3,000.00 |